2009
DOI: 10.1016/j.jclinane.2008.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative hypertension: a review of current and emerging therapeutic agents,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
0
4

Year Published

2010
2010
2019
2019

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(42 citation statements)
references
References 135 publications
0
38
0
4
Order By: Relevance
“…This central mechanism also appears to be mediated by agonist activity on receptors imidazoline I1 [8,9]. Such a central effectresults in a better cardiovascular and endocrine response to surgical stimulation and the laryngoscopy.…”
Section: Therapymentioning
confidence: 99%
See 2 more Smart Citations
“…This central mechanism also appears to be mediated by agonist activity on receptors imidazoline I1 [8,9]. Such a central effectresults in a better cardiovascular and endocrine response to surgical stimulation and the laryngoscopy.…”
Section: Therapymentioning
confidence: 99%
“…The clevidipine is metabolized by esterases of RBCs, allowing safe use in patients with liver disease. Patients with a known hypersensitivity to eggs or soya, however, cannot take this medicine [9]. In addition to lowering blood pressure, the clevidipine increases coronary blood flow, stroke volume and cardiac output.…”
Section: Clevidipinementioning
confidence: 99%
See 1 more Smart Citation
“…However, it is unclear whether postponing a procedure to enable preoperative control of blood pressure actually reduces the risk of these events [105].…”
Section: Hypertensionmentioning
confidence: 99%
“…However, there is no evidence of reduced myocardial ischemia related to its use in the perioperative period 257 .…”
Section: Perioperative Use Of Nitroglycerinmentioning
confidence: 99%